Clinical Trials Directory

Trials / Unknown

UnknownNCT05849324

Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent or Straight Needles

The Difference of Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent Needle Compared to Straight Needle: a Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
260 (estimated)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study was to compare intravascular injection rates during LTFESI between commonly used straight and bent chiba needles.

Detailed description

Lumbar transforaminal epidural steroid injection (LTFESI) is widely used in clinical practice to effectively deliver injectate into the ventral epidural space. Complications associated with intravascular injection such as spinal cord infarction and paraplegia can occur during LTFESI. The incidence of intravascular injection during LTFESI was known as 9.9% \~ 17.7%. To improve the safety of the procedure, avoidance of intravascular injection is crucial, for which appropriate needle selection is important. Currently, the most commonly used block needles in LTFESI are straight or bent chiba needles. The primary aim of this study was to compare intravascular injection rates during LTFESI between commonly used straight and bent chiba needles.

Conditions

Interventions

TypeNameDescription
DEVICEStraight needleLumbar transforaminal epidural steroid injection is a useful option in the diagnosis and treatment of lumbar radicular pain. During lumbar transforaminal epidural steroid injection, straight needle is going to be used.
DEVICEBent needleLumbar transforaminal epidural steroid injection is a useful option in the diagnosis and treatment of lumbar radicular pain. During lumbar transforaminal epidural steroid injection, bent needle is going to be used.

Timeline

Start date
2023-04-27
Primary completion
2023-11-30
Completion
2023-12-31
First posted
2023-05-08
Last updated
2023-05-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05849324. Inclusion in this directory is not an endorsement.